IRLAB Therapeutics AB (publ) Free Cash Flow Generation Index

Latest as of September 2025: 1.00x

IRLAB Therapeutics AB (publ) free cash flow generation index. IRLAB Therapeutics AB (publ) (IRLAB-A) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of Skr5.26 Million represents 1% of operating cash flow (Skr5.26 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

Skr5.26 Million
SEK

Operating Cash Flow

Skr5.26 Million
SEK

Capital Expenditures

Skr0.00
SEK

Free Cash Flow Generation Index of IRLAB Therapeutics AB (publ) (2021–2021)

Free cash flow generation index of IRLAB Therapeutics AB (publ) from 2021 to 2021. Historical FCF Generation Index trend for IRLAB Therapeutics AB (publ) across 1 annual periods. See IRLAB-A FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

IRLAB Therapeutics AB (publ) Free Cash Flow Generation Index by Year (2021–2021)

IRLAB Therapeutics AB (publ) free cash flow generation index by year from 2021 to 2021. Year-by-year Free Cash Flow Generation Index for IRLAB Therapeutics AB (publ). For the full cash flow conversion analysis, see IRLAB Therapeutics AB (publ) cash conversion from operations.

Year FCG Index Free Cash Flow (SEK) Operating CF Capital Expenditures YoY Change
2021 0.99x Skr127.93 Million Skr128.64 Million Skr708.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).